羚锐制药 百普赛斯 九安医疗 昭衍新药 康龙化成 奕瑞科技 分时图 日K线 周K线 月K线 21.16 -0.21 -0.98% 1.31% 0.89% 0.42% 0.00% 0.42% 0.89% 1.31% 21.09 21.18 21.28 21.37 21.46 21.56 21.65 09:30 10:30 11:30/13:00 14:00 15:00 0 9万 18万 28万 中国经济网北京1月13日讯据同花顺（300033）数据显示，在刚过去的2025年，泰康医疗健康股票发起 C、泰康医疗健康股票发起A分别下跌13.45%和13.02%。 该基金2025年三季度前十大重仓股为晶泰控股、康龙化成（300759）、方舟健客、三生制药、昭衍新药 （603127）、九安医疗（002432）、奕瑞科技、羚锐制药（600285）、百普赛斯（301080）、毕得医 药。 基金经理傅洪哲曾任中欧基金管理有限公司高级研究员。2019年7月加入泰康公募，后任泰康基金股票 研究员，2022年3月8日至今任基金经理。 | 名标 | | | 复权单位净 累计单位 规模 亿 基金成立日 | | 喜余经理 | | --- ...

Group 1 - The core viewpoint of the news is that the Taikang Medical Health Fund has experienced significant declines in its stock performance for both Class C and Class A shares, with decreases of 13.45% and 13.02% respectively in 2025 [1][2] - The top ten holdings of the fund as of the third quarter of 2025 include companies such as Jingtai Holdings, Kanglong Chemical, Fangzhou Jianke, Sanofi Pharmaceutical, Zhaoyan New Drug, Jiuan Medical, Yirui Technology, Lingrui Pharmaceutical, Baipusais, and Bid Medical [1] - The fund manager, Fu Hongzhe, has a background as a senior researcher at China Europe Fund Management Co., Ltd. and has been with Taikang since July 2019, becoming the fund manager on March 8, 2022 [1]

Core Viewpoint - The report highlights a significant institutional ownership in the company, with a total of 14 institutional investors holding 3.94 billion shares, representing 51.87% of the total share capital as of August 25, 2025 [1] Group 1: Institutional Ownership - A total of 14 institutional investors disclosed their holdings in the company, with a combined shareholding of 3.94 billion shares, accounting for 51.87% of the total share capital [1] - The top ten institutional investors collectively hold 51.84% of the shares, with a decrease of 3.21 percentage points compared to the previous quarter [1] Group 2: Public Fund Holdings - Two public funds increased their holdings during this period, while three public funds reduced their holdings, with a decrease rate of 0.24% [2] - Four new public funds disclosed their holdings this period, while seven public funds were not disclosed compared to the previous quarter [2] Group 3: Insurance Capital Holdings - One insurance capital entity, China Life Insurance Co., Ltd., reported a slight decrease in holdings during this period [2]